Immuno-Oncology with Mass Cytometry
Emerging Approaches to Improving Adoptive Cell Therapy
Flow cytometry with CyTOF® is enabling improved profiling of CAR (chimeric antigen receptor) cell products and their functional characteristics.
The use of CAR cells as therapeutic agents in cancer is expanding at a rapid pace, but significant challenges remain. Investigators are taking innovative approaches to address these challenges.
The expert research shared here spans diverse aspects of CAR cell therapeutic development, from expanding our understanding of immune cell function to improving CAR T manufacturing to monitoring CAR cells in clinical research trials.
» Contact us for more info.
» Learn more about immune profiling with CyTOF.
Expanding CAR T Cell Profiling to Accelerate Therapeutic Insights
Associate Manager, Scientist, 2seventy bio™
Introducing CyTOF XT™ and Maxpar® Direct™ Assays for Efficient High-Content Immune Profiling
Emily Thrash, PhD
Field Application Specialist, Proteomics, Standard BioTools™